"Manual Dexterity and Oculomotor Control in Schizophrenia"

NCT02826629 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2017-10-19

No results posted yet for this study

Summary

The investigators recently showed that visuomotor integration was significantly altered in schizophrenic patients during: (i) a grip force task (Teremetz et al., 2014), and (ii) a saccadic paradigm (oculomotor task)(Amado et al., 2008). Given this findings, the investigators propose a combined study of oculomotor and grip force control to better characterize the sensorimotor integration deficit. This approach may allow for identification of behavioural biomarkers of vulnerability to develop schizophrenia.

Conditions

Interventions

DEVICE

Manual dexterity

Control of manual dexterity will be assessed by a force sensor (Power Grip Manipulandum, PGM)

DEVICE

Oculomotor movements

Oculomotor movements during behavioral task will be recorded using a video-oculography device

DEVICE

TMS coupled to EMG recording

The involvement of cortical inhibition in this volitional inhibition task will be studied by neuronavigation guided TMS coupled to EMG recording

OTHER

Psychopathological evaluations

OTHER

Neuropsychological evaluations

Sponsors & Collaborators

  • University of Paris 5 - Rene Descartes

    collaborator OTHER
  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV
  • Centre Hospitalier St Anne

    lead OTHER

Principal Investigators

  • Isabelle Amado, Dr · CHSA

  • Pavel Lindberg, PhD · Institut National de la Santé Et de la Recherche Médicale, France

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-26
Primary Completion
2018-09-30
Completion
2019-01-31

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02826629 on ClinicalTrials.gov